Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

No quotes available
-- USD   0.00%
08/22 Pfizer buying maker of prostate-cancer drug Xtandi for $14B
08/16 ALLERGAN : Vitenas Cosmetic Surgery Among Top In The Nation
08/10 ALLERGAN : Notes Strong Second Quarter in Earnings Report
 SummaryQuotesNewsCalendarCompanyFinancials 
Company
Allergan, Inc. operates as a global healthcare company.It engages in the developing and commercializing innovative specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity... 
Sector
Pharmaceuticals
Calendar
10/25Earnings Release
More about the company
Latest news on ALLERGAN, INC.
08/22 Pfizer buying maker of prostate-cancer drug Xtandi for $14B
08/17 ALLERGAN : Assigned Patent
08/16 ALLERGAN : Vitenas Cosmetic Surgery Among Top In The Nation
08/15 ALLERGAN : Vitenas Cosmetic Surgery Among Top In The Nation
08/11 TEVA PHARMACEUTICAL INDUSTRIES : Announces Acquisition of Anda Inc.
08/10 ALLERGAN : Assigned Patent
08/10 ALLERGAN : Notes Strong Second Quarter in Earnings Report
08/09 ALLERGAN : becomes largest shareholder in Teva
08/08 ALLERGAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
08/08 ALLERGAN : Announces the Arrival of Juvederm Volbella for Lip Wrinkle
More news
Sector news : Pharmaceuticals - NEC
08/23DJU.S. Lawmakers Plan Hearing Over Wave of Agriculture Mergers
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/23DJNew CFO Tops Off Shake-Up At Valeant -- WSJ
08/22DJValeant Names Zoetis Executive as Financial Chief--Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chairman & President
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Maria Teresa Hilado Director
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON15.98%325 925
ROCHE HOLDING LTD.-12.26%219 531
NOVARTIS AG-10.20%213 663
PFIZER INC.7.93%211 327
MERCK & CO., INC.20.31%175 729
More Results